Malin Corporation plc

ISE:MLC.IR

5.8 (EUR) • At close October 31, 2024
Bedrijfsnaam Malin Corporation plc
Symbool MLC.IR
Munteenheid EUR
Prijs 5.8
Beurswaarde 109,557,940
Dividendpercentage 0%
52-weken bereik 3.84 - 6.45
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Darragh Fergal Lyons
Website https://malinplc.com

An error occurred while fetching data.

Over Malin Corporation plc

Malin Corporation plc, through its subsidiaries, operates in the life sciences industry in Ireland and the United States. It offers life-saving cell and gene therapies for patients with high unmet medical need; medicines to address unmet needs in cancer, infection, and autoimmune diseases; and treatment of recurrent vulvovaginal candidiasis, an

Vergelijkbare Aandelen

Median Technologies SA logo

Median Technologies SA

ALMDT.PA

4.105 EUR

Biosynex SA logo

Biosynex SA

ALBIO.PA

2.76 EUR

Nanobiotix S.A. logo

Nanobiotix S.A.

NANO.PA

3.954 EUR

Genfit S.A. logo

Genfit S.A.

GNFT.PA

4.89 EUR

Cellectis S.A. logo

Cellectis S.A.

ALCLS.PA

1.71 EUR

DBV Technologies S.A. logo

DBV Technologies S.A.

DBV.PA

2.136 EUR

MedinCell S.A. logo

MedinCell S.A.

MEDCL.PA

17.94 EUR

UG Healthcare Corporation Limited logo

UG Healthcare Corporation Limited

8K7.SI

0.123 SGD

Innate Pharma S.A. logo

Innate Pharma S.A.

IPH.PA

1.61 EUR

Financiële Gegevens

Cijfers zijn in miljoenen (EUR)

Cijfers zijn in miljoenen (EUR)